Search clinical trials for: Etesevimab

Total 7 results

University of Milano Bicocca

Recruiting

COVID-19 and Disease Progression to the Severe Form: A Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 (CONDIVIDIAMO)

COVID-19

Italy
Eli Lilly and Company
Shanghai Junshi Bioscience Co., Ltd.; AbCellera Biologics Inc.

Completed

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness (BLAZE-1)

COVID-19

United States
Erin McCreary
University of Pittsburgh

Terminated

UPMC OPTIMISE-C19 Trial, a COVID-19 Study (OPTIMISE-C19)

Covid19

United States
Azienda Ospedaliera Universitaria Integrata Verona
Agenzia Italiana del Farmaco; Azienda Sanitaria-Universitaria Integrata di...

Terminated

Non-inferiority Trial on Monoclonal Antibodies in COVID-19 (MANTICO)

COVID-19

Italy
Eli Lilly and Company
GlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...

Completed

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)

COVID-19

United States, Puerto Rico, Argentina
Eli Lilly and Company
National Institute of Allergy and Infectious Diseases (NIAID); Shanghai Junshi... and other collaborators

Completed

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff (BLAZE-2)

COVID-19 | SARS-CoV2

United States
Eli Lilly and Company
Shanghai Junshi Bioscience Co., Ltd.

Completed

A Study of LY3832479 (LY-CoV016) in Healthy Participants 1

Healthy

United States

Search clinical trials for: Etesevimab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations